A refugee daughter’s pilgrimage
I no longer flinch when someone asks if my family were boat people: it is a part of who I am. Their story is also my story.
Outside of journalism, I like to explore personal stories through creative writing. My memoir essay, “A refugee daughter’s pilgrimage,” is published in the latest issue of the Australian literary magazine Meanjin.
#memoir #lifewriting #refugees @meanjin.bsky.social
meanjin.com.au/memoir/a-ref...
18.07.2025 16:18 — 👍 0 🔁 0 💬 0 📌 0
London Faces More Setbacks in a ‘Grueling Fight’ for Listings
London’s bid to revive its shrinking stock market has faced a series of setbacks in recent weeks, with companies shifting listings and IPO plans from the market.
My colleagues and I wrote about how London’s bid to revive its shrinking stock market has faced a series of setbacks in recent weeks, with companies shifting listings and IPO plans from the market.
#markets #uk #stocks #stockmarket #stocklistings #ipos
www.bloomberg.com/news/article...
06.06.2025 09:36 — 👍 0 🔁 0 💬 0 📌 0
Swiss Chocolate Stocks Diverge as High Cocoa Prices Take Toll
Shares in two of Switzerland’s biggest chocolatiers are on markedly different courses this year as soaring cocoa prices prove a tougher obstacle for one than they do for the other.
I teamed up with a colleague to write about the divergence between two Swiss chocolate stocks amid soaring cocoa prices. Lindt shares are hovering near a record high, while Barry Callebaut fell to a 2011 low last month.
#markets #stocks #swiss #chocolate
www.bloomberg.com/news/article...
06.06.2025 09:30 — 👍 0 🔁 0 💬 0 📌 0
An Island Outbreak Becomes Testing Ground For New Vaccine Market
Hi, it’s Lisa in London, where I’m keeping an eye on the outbreak of a mosquito-borne disease in the Reunion Island, along with challenges facing the vaccine makers. But before we get to that...
ICYMI: I recently wrote about a clutch of volcanic islands in the Indian Ocean being the real-life battleground between a virus that could ignite a pandemic — chikungunya — and the first vaccine to address it.
#health #vaccines #chikungunya #prognosisnewsletter
www.bloomberg.com/news/newslet...
06.06.2025 09:24 — 👍 0 🔁 1 💬 0 📌 0
A baby surrounded by medical devices is being held up by someone with gloved hands. A headline reads: "Baby Is Healed With World's First Personalized Gene-Editing Treatment." Photo courtesy of Children's Hospital of Pennsylvania.
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy
15.05.2025 17:09 — 👍 1654 🔁 294 💬 92 📌 93
Trump’s Trade War Spares an Industry Europe Dominates: Hearing Aids
The roughly $12 billion global hearing aids sector is likely to continue to be led by Europe — especially Denmark — for some time to come.
My story published today looks at how hearing aids have been spared from US President Donald Trump’s trade war, with Europe’s dominance in this sector set to continue.
#hearingaids #tariffs #trump #europe #denmark #siliconvalleyofsound
www.bloomberg.com/news/article...
15.05.2025 19:55 — 👍 0 🔁 1 💬 0 📌 0
The Price of Remission
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked ...
New from @davidarmstrongx.bsky.social:
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
08.05.2025 11:30 — 👍 5202 🔁 2041 💬 272 📌 195
John Green has written a new, already best-selling nonfiction book on tuberculosis that asks a pointed question: Why does a fully curable disease still kill more than a million people a year? Read or listen to our conversation with the author. nyti.ms/4l6WykQ
27.03.2025 23:12 — 👍 416 🔁 74 💬 18 📌 5
Medical Research at Columbia Is Imperiled After Trump Terminates Funding
Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
After the Trump administration abruptly cut $400 million in funding to Columbia University, dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
18.03.2025 19:08 — 👍 248 🔁 108 💬 31 📌 9
Covid’s Long-Term Effects on the Lungs, Gut, Brain and More
Five years on, scientists are starting to understand how the virus can lead to long-term, sometimes invisible changes.
Five years after the WHO declared the Covid-19 pandemic, scientists are getting a clearer picture of how the virus can lead to long-term, sometimes invisible changes.
10.03.2025 18:35 — 👍 181 🔁 61 💬 11 📌 8
National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval
Vaccines. Fluoride. Autism. Communications involving these and 20 other “controversial, high profile, or sensitive” topics will get extra scrutiny under Health Secretary Robert F. Kennedy Jr.
NEW: Vaccines. Fluoride. Autism.
Communications involving these and 20 other “controversial, high profile, or sensitive” topics will get extra scrutiny under Health Secretary Robert F. Kennedy Jr.
By @anniewaldman.bsky.social and @lisalsong.bsky.social
10.03.2025 17:47 — 👍 748 🔁 318 💬 50 📌 48
Llamas Are Now Being Used in Search for New Obesity Drugs
Hi, it’s Lisa in London, where I’ve been learning about llamas helping find potential obesity treatments for humans. But before we get to that...
My latest piece for Bloomberg’s Prognosis newsletter is about a biotech company turning to llama antibodies in the search for new obesity drugs.
#health #biotech #obesitydrugs #llamas #prognosisnewsletter
www.bloomberg.com/news/newslet...
07.03.2025 13:10 — 👍 1 🔁 0 💬 0 📌 0
Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
SCOOP > The Trump administration is weighing pulling Moderna's contract to create bird flu shots, part of a bigger effort to question spending on messenger RNA-based vaccines
Madison Muller, @rileyraygriffin.bsky.social and @ikeswetlitz.bsky.social
www.bloomberg.com/news/article...
26.02.2025 22:46 — 👍 337 🔁 221 💬 37 📌 121
Asparagus tart with Gruyère cheese. #homecooking #sundaylunch
23.02.2025 22:47 — 👍 9 🔁 0 💬 1 📌 0
Novo Shares Hit as Super Bowl Weight-Loss Ad Shows Copycat Risk
Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat products underscored the challenge to its weight-loss blockbuster drug.
Novo Nordisk shares had their worst week this year, after a Super Bowl advertisement touting copycat products underscored the challenge to its weight-loss blockbuster drug. Here’s my story with Naomi Kresge via @bloomberg.com
#markets #shares #weightlossdrugs
www.bloomberg.com/news/article...
14.02.2025 16:32 — 👍 1 🔁 0 💬 0 📌 0
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
The Trump administration's stop-work order on USAID left thousands of volunteers around the world w/ experimental drugs + medical devices in their bodies – cut off from care by researchers running clinical trials, in violation of the fundamental principles of research www.nytimes.com/2025/02/06/h...
07.02.2025 01:48 — 👍 72 🔁 58 💬 3 📌 4
Swiss Hearing-Aid Maker Transforms Into Unlikely AI Stock Winner
Hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays.
My story published today looks at how hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays. Via @bloomberg.com
#markets #stocks #hearingaids #ai
www.bloomberg.com/news/article...
30.01.2025 13:09 — 👍 3 🔁 0 💬 0 📌 0
LVMH Reclaims Title of Europe’s Most Valuable Stock From Novo
It’s taken LVMH nearly a year-and-a-half to regain its spot as Europe’s biggest stock from Novo Nordisk A/S.
Danish drugmaker Novo Nordisk lost its crown as Europe’s most valuable listed company on Friday, after its market capitalisation fell below that of French luxury-goods maker LVMH. Here’s my story with Kit Rees via @bloomberg.com
#markets #stocks
www.bloomberg.com/news/article...
17.01.2025 16:47 — 👍 3 🔁 1 💬 0 📌 0
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.
My latest article published today is about Alzheimer’s drugs and the developments to watch this year, as investors eye the next obesity-like market opportunity. Via @bloomberg.com
#markets #stocks #alzheimersdrugs
www.bloomberg.com/news/article...
10.01.2025 12:01 — 👍 1 🔁 0 💬 0 📌 0
Scientists Turn Mosquitoes Into Tiny Weapons to Fight Disease
Billions of bacteria-infected mosquitoes are being weaponized by cities.
Scientists are combatting mosquito-borne sicknesses by infecting the insects with bacteria to fight the diseases they carry.
10.01.2025 05:09 — 👍 156 🔁 37 💬 8 📌 8
Hot Obesity Drug Market Will Keep Investors Gripped Next Year
Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharma’s hottest market.
2024 has been a volatile year for investors in weight-loss drug developers. My latest article with Angel Adegbesan delves into what happened this year and what to watch in 2025. Via @bloomberg.com
#stocks #markets #investing #obesitydrugs #pharma
www.bloomberg.com/news/article...
23.12.2024 13:50 — 👍 2 🔁 0 💬 0 📌 0
Scientific Director, #MEAction
Stanford Med
Université de Montréal
TIME100 Health 2024
#ME, #EDS, #POTS, #LongCOVID
Views my own
exceedhergrasp1 on Twitter
A nonprofit news site chronicling the #LongCOVID crisis. Founded by journalists @BetsyLadyzhets.bsky.social & @MilesWGriffis.bsky.social
Website: thesicktimes.org
Newsletter: thesicktimes.org/newsletter
Donate: the-sick-times.fundjournalism.org
Past & Present Fellow, Institute of Historical Research. Writing about central Europe, families, psychology and art + objects in the TLS, Granta, Guardian etc.
Senior markets editor at Bloomberg News.
Discussing all aspects of the construction of the historical narrative
https://historicalfictionsresearch.org/
Novelist with Penguin Viking, creative writing teacher with the University of Manchester and Faber Academy. Hiking, gardening, crochet, coeliac disease: old-person stuff.
Reporter at Bloomberg News
Health tech correspondent at STAT News (www.statnews.com)
Share tips: katie.palmer@statnews.com
Signal: palmer.01
Global health reporter, The New York Times. Former correspondent in South Asia, Africa, Latin America and the MidEast. Author, 28 Stories of AIDS in Africa; Promised the Moon. Baker. Canoe tripper. Disease nerd. Lover of a fat novel and Earl Grey tea.
Health Journalist 🇨🇦 Contributor CTVNews
Host Canadian Institute for Health information Podcast, contributor to Santis Health
But mostly a professional hypochondriac
By way of 🇬🇧 > 🇯🇵 > 🇸🇬 > 🇺🇸 now Washington, DC.
Executive editor for Equality at Bloomberg News: https://www.bloomberg.com/equality
Tips? Story ideas? akitanaka@bloomberg.net
Or email the Equality team: newsequality@bloomberg.net
Bloomberg News finance reporter in London.
Tips at dgriffin10@bloomberg.net//Signal: donalgriffin.97
Stories: www.bloomberg.com/authors/AQDQOc_taYU/donal-griffin
Do investigations for the FT, into dubious accounting and dodgy characters mainly. Wrote a book called Money Men about a spectacular fraud
Considered thinking - Sustainable scholarship - Artisanal histories.
Reading / writing / teaching / mentoring. @King's College London.
Occasional history musings on cities, memory, youth, Australia.
Mumbai bureau chief at the Financial Times.
Previously with Bloomberg in India, Pakistan, Nigeria and the UK.
https://chriskay.co.uk/
https://www.ft.com/chris-kay
Dublin bureau chief at Bloomberg. Previously TIME.
Western Europe economy team leader at Bloomberg. Posts are not endorsements and opinions are my own.
Stanford GSB ‘25. Former journalist.